End­points ed­i­tors se­lect the top trends of 2022: M&A looks hot as IPOs wane, it's time to see some hard da­ta on AI and can ac­cel­er­at­ed ap­proval re­main in­tact?

It’s time for our hol­i­day break here at End­points News, and like a lot of you, we’ve been prep­ping for 2022.

Any­one who’s spent some time in in­dus­try can tell you the past decade has shoved the drug-hunt­ing field in­to the fore­front of the world’s view of things, gar­ner­ing tens of bil­lions in in­vest­ment as new tech­nolo­gies look to change the land­scape of R&D. And any­one who qual­i­fies for first-in-class and best-in-class can clean up.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER